Product ID: SQMIG35H2248
Monoclonal Antibodies Market Size, Share, Growth Analysis, By Source(Murine, Chimeric), By Production Type(In Vivo, and In Vitro), By Application(Oncology, Autoimmune Diseases), By End Use(Hospitals, Specialty Centers) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2248 |
Region:
Global |
Published Date: May, 2024
Pages:
211
|
Tables:
119 |
Figures:
75
Monoclonal Antibodies Market Insights
Global Monoclonal Antibodies Market size was valued at USD 210 billion in 2022 and is poised to grow from USD 233.1 billion in 2023 to USD 537.19 billion by 2031, growing at a CAGR of 11% in the forecast period (2024-2031).
Antibodies produced from a single-cell lineage by cloning a white blood cell are known as monoclonal antibodies (mAbs). Monoclonal antibodies are used for drug development or as drugs to effectively treat different types of diseases. The surge in the incidence of chronic diseases around the world is projected to primarily bolster the demand for monoclonal antibodies over the coming years. High investments in medical research and development and advancements in biotechnology are also predicted to bolster the sales of monoclonal antibodies across the forecast period. Advancements in molecular biology are projected to boost the sales of monoclonal antibodies in the future. Moreover, the expanding application scope of monoclonal antibodies in different healthcare, pharmaceutical, and biotechnology applications will also create new opportunities for monoclonal antibody suppliers in the long run. On the contrary, high development costs, long time-to-market, and safety concerns are estimated to be top constraints for monoclonal antibody market development going forward.
To get more reports on the above market click here to Buy The Report
Monoclonal Antibodies Market Segmental Analysis
The Global Monoclonal Antibodies Market is segmented based on production type, source, application, end use and region. In terms of production type, the market is bifurcated into in vivo and in vitro. Based on application, the market is divided into oncology, autoimmune diseases, infectious diseases, neurological diseases, and others. Based on source, the market is bifurcated into murine, chimeric, humanized, and human. In terms of end use, the market is segmented into hospitals, specialty centers, and others. Based on region, the market is segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa.
Analysis by Source
Monoclonal antibodies sourced from humans are projected to account for a dominant share of the Global Monoclonal Antibodies Market. Monoclonal antibodies derived from humans are less immunogenic and safer for use in any kind of healthcare application as compared to mAbs from other sources. Advancements in genetic engineering and genomics will help this segment maintain its dominance.
Demand for humanized monoclonal antibodies is expected to increase at the fastest CAGR over the coming years. Lower immunogenicity as compared to chimeric mAbs is a key factor promoting market growth via this segment. High investments in biotechnology research will also foster innovation in this segment going forward.
Analysis by Production Type
In vitro production is anticipated to account for a substantial share of the Global Monoclonal Antibodies Market going forward. A lower risk of contamination and high economic viability in long-term production are key prospects that allow this segment to hold a high market share. Rising availability of serum-free culture media and semi-permeable membrane-based systems is also slated to help this segment maintain its dominance in the long run.
Meanwhile, demand for in vivo production of monoclonal antibodies is projected to increase at a rapid pace across the forecast period and beyond. Production of high concentration of mAbs at a very low cost compared to in vitro production techniques is what allows this segment to promote market development going forward.
To get detailed analysis on other segments, Request For Free Sample Report
Monoclonal Antibodies Market Regional Insights
North America is estimated to account for a substantial share of the Global Monoclonal Antibodies Market owing to high investments in medical R&D and the presence of key biotechnology companies. Supportive government initiatives to promote cancer research are also estimated to bolster monoclonal antibody demand in this region. The United States is expected to lead the market growth in this region followed by Canada. of a developed healthcare infrastructure in the countries also bolsters North America’s dominance.
Meanwhile, the demand for monoclonal antibodies in the Asia Pacific region is slated to rise at a robust pace over the coming years. Rapidly increasing patient pool of people affected chronic diseases such as cancer and cardiovascular disorders is projected to bolster monoclonal antibody market growth in this region. China, India, Japan, and South Korea are estimated to be the top markets for monoclonal antibody suppliers in this region. High emphasis on healthcare infrastructure development will also favor monoclonal antibody sales in the Asia Pacific region through 2031.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Monoclonal Antibodies Market Dynamics
Drivers
Surge in Prevalence of Chronic Diseases
- Rising incidence of chronic diseases around the world has boosted the demand for novel treatments and therapeutics, which in turn is driving investments in medical R&D. Monoclonal antibodies play a crucial role in R&D for therapeutics of many chronic diseases and this could bolster market growth going forward.
Rising Use in Biopharmaceutical Research
- High investments in life science and biotechnology research are projected to boost the demand for monoclonal antibodies over the coming years as they are used for biomarker discovery, target identification, and other important stages of biopharmaceutical research.
Restraints
High Development Costs
- Monoclonal antibodies are developed using complex and lengthy research techniques and procedures, which adds up to the R&D costs. These high development costs result in expensive end products and therefore impede market growth as well.
Long Time-to-Market
- Monoclonal antibodies are developed using complex and lengthy techniques and procedures, which is why they are also subject to stringent regulatory testing for approval. Failure in these approval processes increases time-to-market and slows down market development.
Request Free Customization of this report to help us to meet your business objectives.
Monoclonal Antibodies Market Competitive Landscape
Monoclonal antibody companies should focus on reducing their time-to-market and fast track their commercialization processes to boost revenue generation. Collaborations and partnerships will be of the essence for companies looking to hasten their product launches and gain a competitive advantage over other market players. Monoclonal antibody market players can also take advantage of supportive government initiatives and grants for medical research related to monoclonal antibodies.
Top Player’s Company Profiles
- Abbott Laboratories
- Johnson & Johnson Services Inc.
- Sanofi S.A.
- Bristol Myers Squibb
- F. Hoffman-La Roche Ltd.
- GlaxoSmithKline plc
- Merck KGaA
- Novo Nordisk A/S
- Novartis
- Bayer AG
- Daiichi Sankyo Company Limited
- Biogen Inc.
- Thermo Fisher Scientific Inc.
- Viatris Inc.
- Eli Lilly and Company
Recent Developments
- In March 2024, Roche, a leading Swiss pharmaceutical organization, announced the launch of monoclonal antibody for two critical eye diseases in the Indian market. The newly launched Vabysmo was launched for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME).
- In January 2024, Calluna Pharma, a new entity formed by the merger of Oxitope Pharma and Arxx Therapeutics, announced that it has raised USD 81 million in a Series A funding round. The company intended to use these funds to advance its monoclonal antibody pipeline, which has 4 high potential candidates.
- In December 2023, KBI Biopharma launched a new platform to streamline the development and manufacturing of monoclonal antibodies. The new offering is called SUREmAb and is based on KBI’s SUREtechnology Platform.
Monoclonal Antibodies Key Market Trends
- Biosimilar and Biobetters: Patent expiry of monoclonal antibodies will offer attractive opportunities in the name of biosimilar and biobetter development. Companies can invest in research and development of biosimilars of popular monoclonal antibodies whose patent is going to expire soon and make huge profits in the long run.
Monoclonal Antibodies Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per Skyquest analysis, growing prevalence of chronic diseases, high investments in medical R&D, and advancements in molecular biology are projected to augment the demand for monoclonal antibodies across the forecast period. However, safety concerns, lengthy time-to-market, high costs of development, and presence of stringent regulatory procedures are forecasted to impede monoclonal antibody market growth potential. North America is estimated to dominate the demand for monoclonal antibodies over the coming years owing to the presence of a developed healthcare ecosystem. Development of biosimilars for patent expired monoclonal antibodies will create new opportunities for monoclonal antibody companies in the future.
What’s Included
NA
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 210 billion |
| Market size value in 2031 | USD 537.19 billion |
| Growth Rate | 11% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Monoclonal Antibodies Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Monoclonal Antibodies Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Monoclonal Antibodies Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Monoclonal Antibodies Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Monoclonal Antibodies Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Monoclonal Antibodies Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
